Cargando…

Characteristics of lactate metabolism phenotype in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a highly heterogeneous cancer, and more effective prognostic markers are needed. Lactic acid has been proved to be an important metabolite involved in cancer development, metastasis, and the tumor microenvironment, affecting the prognosis of patients. The role of la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiacheng, Dong, Keshuai, Zhang, Xin, Li, Chunlei, Yu, Jia, Wang, Weixing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640573/ https://www.ncbi.nlm.nih.gov/pubmed/37952028 http://dx.doi.org/10.1038/s41598-023-47065-0

Ejemplares similares

SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2022)

GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling
por: Zhang, Xin, et al.
Publicado: (2023)

Construction of a Nomogram to Predict Overall Survival in Patients with Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Kuang, Tianrui, et al.
Publicado: (2023)

Uridine Inhibits Hepatocellular Carcinoma Cell Development by Inducing Ferroptosis
por: Zi, Liuliu, et al.
Publicado: (2023)

Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma
por: Xu, Yiwei, et al.
Publicado: (2023)

Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors
por: Zhang, Lilong, et al.
Publicado: (2022)

Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapy
por: Zhang, Lilong, et al.
Publicado: (2022)

Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma
por: Zhang, Lilong, et al.
Publicado: (2023)

The Prognostic Significance and Potential Mechanism of Prolyl 3-Hydroxylase 1 in Hepatocellular Carcinoma
por: Li, Chunlei, et al.
Publicado: (2022)

EXO1 Plays a Carcinogenic Role in Hepatocellular Carcinoma and is related to the regulation of FOXP3
por: Yang, Guang, et al.
Publicado: (2020)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma
por: Li, Yue, et al.
Publicado: (2022)

Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy()()
por: Zhang, Jing-Ping, et al.
Publicado: (2015)

Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma
por: Fessas, Petros, et al.
Publicado: (2021)

Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma
por: Tian, Siyuan, et al.
Publicado: (2021)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)

Key Molecules of Fatty Acid Metabolism in Gastric Cancer
por: Li, Chunlei, et al.
Publicado: (2022)

Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer
por: Shi, Rui, et al.
Publicado: (2023)

Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis
por: Kong, Weihao, et al.
Publicado: (2018)

Identification of Prognostic Genes in Hepatocellular Carcinoma
por: Bai, Wenhui, et al.
Publicado: (2022)

Protein succinylation associated with the progress of hepatocellular carcinoma
por: Bai, Wenhui, et al.
Publicado: (2022)

DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6
por: Zhang, Xiaochao, et al.
Publicado: (2022)

Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)
por: Huang, Jingquan, et al.
Publicado: (2023)

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
por: Faloppi, Luca, et al.
Publicado: (2016)

Lactate and Myocardiac Energy Metabolism
por: Dong, Shuohui, et al.
Publicado: (2021)

Prognostic value of controlling nutritional status on clinical and survival outcomes in cancer patients treated with immunotherapy
por: Zhang, Jiacheng, et al.
Publicado: (2023)

d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
por: Han, Shulan, et al.
Publicado: (2023)

Lactate metabolism in human health and disease
por: Li, Xiaolu, et al.
Publicado: (2022)

Metabolism-Related Gene Pairs to Predict the Clinical Outcome and Molecular Characteristics of Early Hepatocellular Carcinoma
por: Wu, Junling, et al.
Publicado: (2022)

Metabolic Profiling Study of Yang Deficiency Syndrome in Hepatocellular Carcinoma by H1 NMR and Pattern Recognition
por: Huang, Xueqiang, et al.
Publicado: (2012)

Endothelial Cell: Lactate Metabolic Player in Organ Regeneration
por: Zhang, Lanlan, et al.
Publicado: (2021)

Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2022)

Molecular and Metabolic Phenotyping of Hepatocellular Carcinoma for Biomarker Discovery: A Meta-Analysis
por: Anh, Nguyen Hoang, et al.
Publicado: (2023)

Corrigendum: Lactate and Myocardiac Energy Metabolism
por: Dong, Shuohui, et al.
Publicado: (2022)

A knowledge‐based approach to automated planning for hepatocellular carcinoma
por: Zhang, Yujie, et al.
Publicado: (2017)

Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype
por: Longhitano, Lucia, et al.
Publicado: (2022)

Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
por: Sun, Lei, et al.
Publicado: (2023)

Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma
por: Wang, Zifei, et al.
Publicado: (2022)

m1A methylation modification patterns and metabolic characteristics in hepatocellular carcinoma
por: Tong, Chengcheng, et al.
Publicado: (2022)

miR-136 Inhibits Malignant Progression of Hepatocellular Carcinoma Cells by Targeting Cyclooxygenase 2
por: Jia, Haiyan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l73qhpl78r501gbtj52sdt9cse